| Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL G Palladini, F Lavatelli, P Russo, S Perlini, V Perfetti, T Bosoni, L Obici, ... Blood 107 (10), 3854-3858, 2006 | 358 | 2006 |
| Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine G Palladini, P Russo, T Bosoni, L Verga, G Sarais, F Lavatelli, ... Clinical chemistry 55 (3), 499-504, 2009 | 305 | 2009 |
| The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL) G Palladini, V Perfetti, S Perlini, L Obici, F Lavatelli, R Caccialanza, ... Blood 105 (7), 2949-2951, 2005 | 258 | 2005 |
| Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis G Palladini, P Russo, M Nuvolone, F Lavatelli, V Perfetti, L Obici, G Merlini Blood, The Journal of the American Society of Hematology 110 (2), 787-788, 2007 | 244 | 2007 |
| Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue F Brambilla, F Lavatelli, D Di Silvestre, V Valentini, R Rossi, G Palladini, ... Blood, The Journal of the American Society of Hematology 119 (8), 1844-1847, 2012 | 209 | 2012 |
| A practical approach to the diagnosis of systemic amyloidoses C Fernández de Larrea, L Verga, P Morbini, C Klersy, F Lavatelli, A Foli, ... Blood, The Journal of the American Society of Hematology 125 (14), 2239-2244, 2015 | 204 | 2015 |
| Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach G Palladini, P Milani, A Foli, L Obici, F Lavatelli, M Nuvolone, ... haematologica 99 (4), 743, 2014 | 173 | 2014 |
| Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue F Lavatelli, DH Perlman, B Spencer, T Prokaeva, ME McComb, ... Molecular & Cellular Proteomics 7 (8), 1570-1583, 2008 | 152 | 2008 |
| A Caenorhabditis elegans–based assay recognizes immunoglobulin light chains causing heart amyloidosis L Diomede, P Rognoni, F Lavatelli, M Romeo, E del Favero, L Cantu, ... Blood, The Journal of the American Society of Hematology 123 (23), 3543-3552, 2014 | 150 | 2014 |
| Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. L Obici, S Raimondi, F Lavatelli, V Bellotti, G Merlini Arthritis and rheumatism 61 (10), 1435-1440, 2009 | 147 | 2009 |
| Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure G Palladini, A Foli, P Milani, P Russo, R Albertini, F Lavatelli, L Obici, ... American journal of hematology 87 (5), 465-471, 2012 | 144 | 2012 |
| Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients G Palladini, P Milani, A Foli, M Vidus Rosin, M Basset, F Lavatelli, ... Leukemia 28 (12), 2311-2316, 2014 | 138 | 2014 |
| Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient P Swuec, F Lavatelli, M Tasaki, C Paissoni, P Rognoni, M Maritan, ... Nature communications 10 (1), 1269, 2019 | 135 | 2019 |
| Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis E Ihse, C Rapezzi, G Merlini, MD Benson, Y Ando, OB Suhr, S Ikeda, ... Amyloid 20 (3), 142-150, 2013 | 125 | 2013 |
| The workings of the amyloid diseases V Bellotti, M Nuvolone, S Giorgetti, L Obici, G Palladini, P Russo, ... Annals of medicine 39 (3), 200-207, 2007 | 108 | 2007 |
| Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide G Palladini, P Russo, A Foli, P Milani, F Lavatelli, L Obici, M Nuvolone, ... Annals of Hematology 91, 89-92, 2012 | 106 | 2012 |
| Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide G Palladini, P Russo, F Lavatelli, M Nuvolone, R Albertini, T Bosoni, ... Annals of hematology 88, 347-350, 2009 | 96 | 2009 |
| A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis G Palladini, P Russo, P Milani, A Foli, F Lavatelli, M Nuvolone, S Perlini, ... Haematologica 98 (3), 433, 2013 | 81 | 2013 |
| Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells E Imperlini, M Gnecchi, P Rognoni, E Sabidò, MC Ciuffreda, G Palladini, ... Scientific reports 7 (1), 15661, 2017 | 78 | 2017 |
| Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis F Lavatelli, E Imperiini, S Orrù, P Rognoni, D Sarnataro, G Palladini, ... The FASEB Journal 29 (11), 4614-4628, 2015 | 73 | 2015 |
